Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)

NCT06193135 is registered in ClinicalTrials.gov with Instituto Valenciano de Infertilidad, IVI VALENCIA as lead sponsor.

NCT NCT06193135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)
Lead sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2025
Completion date
December 31, 2025
Enrollment
318 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, female, reproductive sterility